qRT-PCR analysis of DLGAP1-AS1 expression in three different glioma cell lines (U251, T98G, U87, and LN229) and NHAs found that the expression of this molecule was markedly raised in glioma cell lines in contrast to NHAs. This evidence concerns the gene DLGAP1 and central nervous system cancer.